EUVIMEDOpdag EUVIMED
Metaanalyse

The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis

Mohammad H Abu-Arja iD, Margaret S Shatara, M Fatih Okcu, Susan L McGovern, Jack M Su, Mohamed S Abdelbaki iD

Pediatric Blood & Cancer · 2023

DOI: 10.1002/pbc.30601 ↗

At a glance

Metaanalyse in Pediatric Blood & Cancer, 2023. Written by Mohammad H Abu-Arja and 5 co-authors. Institution: Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA. Major MEDLINE topics: Brain Neoplasms, Central Nervous System Neoplasms, Germinoma. 58 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The role of neoadjuvant chemotherapy in treating patients with metastatic central nervous system (CNS) germinoma is controversial.

Methods

We compared the relapse‐free survival (RFS) of different treatment modalities by performing a meta‐analysis using published data. We summarized all data using standard descriptive statistics. We used the Kaplan–Meier method to estimate RFS and their corresponding 95% confidence intervals (CIs). We used the log‐rank test for the comparison of survival functions.

Results

We identified 97 patients with a median age at presentation of 15 years (range: 7–38). Sites of metastasis were cerebrospinal fluid (CSF) disease only ( n = 12), brain parenchyma ( n = 18), spinal cord ( n = 9), ventricular and CSF ( n = 10), ventricular only ( n = 31), and other ( n = 17). The 3‐year RFS among patients who received any form of radiotherapy was 89% (95% CI: 83–96) compared with 0% for patients who received a chemotherapy‐only regimen ( p = .001). Five‐year RFS among patients who received craniospinal irradiation (CSI) was 92% (95% CI: 84–100) compared with 76.4% (95% CI: 63–90) in the non‐CSI group (with or without neoadjuvant chemotherapy) ( p = .014). Five‐year RFS of patients who received CSI less than 24 Gy with neoadjuvant chemotherapy was 100% compared with 92% (95% CI: 83–100) CSI dose greater than or equal to 24 Gy alone ( p = .3).

Conclusions

Our analysis does not support avoiding spinal irradiation among patients with radiographic metastatic CNS germinoma. Future studies are needed to confirm whether neoadjuvant chemotherapy will allow a reduction of irradiation dose without compromising survival.

Subjects

MeSH terms (MEDLINE)

Brain NeoplasmsCentral Nervous System NeoplasmsGerminomaHumansChildAdolescentYoung AdultAdultNeoadjuvant TherapyNeoplasm Recurrence, LocalSpinal CordAntineoplastic Combined Chemotherapy ProtocolsRetrospective Studies

Author keywords

central nervous systemgerm cell tumorsgerminomaradiotherapy

Authors and institutions

  • Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
  • Division of Hematology and Oncology, St. Louis Children's Hospital, Washington University, School of Medicine in St. Louis, Washington University, St. Louis, Missouri, USA.
  • Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID profiles: Mohammad H Abu-Arja, Mohamed S Abdelbaki

Cite

APA

Abu-Arja, M. H., Shatara, M. S., Okcu, M. F., McGovern, S. L., Su, J. M., & Abdelbaki, M. S. (2023). The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30601

Vancouver

Abu-Arja MH, Shatara MS, Okcu MF, McGovern SL, Su JM, Abdelbaki MS. The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30601

BibTeX
@article{AbuArja2023,
  author = {Abu-Arja, Mohammad H and Shatara, Margaret S and Okcu, M Fatih and McGovern, Susan L and Su, Jack M and Abdelbaki, Mohamed S},
  title = {The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis},
  journal = {Pediatric Blood & Cancer},
  year = {2023},
  doi = {10.1002/pbc.30601}
}
Start for free →